The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025.
CONCLUSIONS: The estimated healthcare cost of DR in Indonesia in 2017 was considerably high, nearly 2% of the 2017 national state budget, and projected to increase significantly to more than threefold in 2025. The highest cost may incur for DR requiring both laser and IVT injection. Therefore, public health intervention to delay or prevent severe DR may substantially reduce the healthcare cost of DR in Indonesia.
PMID: 31285276 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Sasongko MB, Wardhana FS, Febryanto GA, Agni AN, Supanji S, Indrayanti SR, Widayanti TW, Widyaputri F, Widhasari IA, Lestari YD, Adriono GA, Sovani I, Kartasasmita AS Tags: Br J Ophthalmol Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Healthcare Costs | Indonesia Health | International Medicine & Public Health | Opthalmology | Study | UK Health